
About Vascular Flow
Vascular Flow is a company based in Dundee (United Kingdom) founded in 1998. Vascular Flow has raised $16.79 million across 14 funding rounds from investors including NHS Choices, Scottish Enterprise and 3i Group. The company has 10 employees. Vascular Flow offers products and services including Spiral Laminar Flow Technology, Medical Device Development, and Contract Manufacturing. Vascular Flow operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
- Headquarter Dundee, United Kingdom
- Employees 10
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website vascular-flow.com
- Social LinkedIn X
- Legal Name Vascular Flow Technologies Limited
- Date of Incorporation 08 Oct, 1998
- Jurisdiction DUNDEE, SCOTLAND
- Annual Revenue$206.45 K (USD)22as on Dec 31, 2018
- Net Profit-$944.89 K (USD)0as on Dec 31, 2021
- Total Equity Funding$16.79M (USD)
in 14 rounds
- InvestorsNHS Choices
& 7 more
- Employee Count10
Products & Services of Vascular Flow
Vascular Flow offers a comprehensive portfolio of products and services, including Spiral Laminar Flow Technology, Medical Device Development, and Contract Manufacturing.
Technology that restores natural blood flow in cardiovascular devices.
Services for developing cardiovascular devices from concept to market.
Assembly and packaging of medical devices in ISO Class 7 cleanrooms.
Funding Insights of Vascular Flow
Vascular Flow has successfully raised a total of $16.79M across 14 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.79M
- Total Rounds 14
- Investors Count 8
Latest 10 of 14 funding rounds of Vascular Flow with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | – | Grant | β | β | |
| Jan 2016 | $4.29M | Series B | β | β | β |
| Jan 2016 | $10.02M | Debt – Conventional | β | β | β |
| Dec 2015 | $4.45M | Series B | β | β | β |
| Feb 2015 | $56,042 | Grant | β | β | |
| Oct 2014 | $63,090 | Grant | β | β | |
| Nov 2013 | $3.51M | Grant | β | β | β |
| Dec 2010 | $473,631 | Series A | β | β | |
| Mar 2010 | $746,995 | Series A | β | β | |
| Jan 2009 | $1.74M | Series A | β | β |
8 investors in total: 8 institutional.
Investors in Vascular Flow
Vascular Flow has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include NHS Choices, Scottish Enterprise and 3i Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Private equity investment firm | 1997 | braveheartgroup.co.uk | Barnsley, United Kingdom | |
Private equity firm focused on mid-market businesses | 1945 | 3i.com | London, United Kingdom | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Business development and leadership training programs are offered to companies. | 1991 | scottish-enterprise.com | Glasgow, United Kingdom | |
Corporate and M&A advisory services are provided across multiple sectors. | 1974 | quaylemunro.com | London, United Kingdom | |
NatWest Group is recognized as a UK-focused banking institution. | – | rbs.com | Edinburgh, United Kingdom | |
Provider of multiple healthcare services for patients | 1948 | nhs.uk | London, United Kingdom |
Investor details for Vascular Flow
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vascular Flow
2 people are tracked at Vascular Flow (2 in leadership); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Bill Allan | CEO and Non-executive Director | Leadership |
Randall Black | Vice President Of Sales | Leadership |
Complete people profiles for Vascular Flow
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vascular Flow
3 dated milestones of Vascular Flow across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Vascular Flow is founded.
- Funding First funding round.
- Funding Latest funding round, Grant,.
Competitors of Vascular Flow
Vascular Flow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| csi360.com | 1989 | Saint Paul, United States | $121.34M | 780 | Devices for treating peripheral and coronary vascular disease are developed. | |
| contegomedical.com | 2005 | Raleigh, United States | $66.01M | – | Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature | |
| angioscore.com | 2003 | Fremont, United States | $87M | – | Scoring balloon catheters for coronary and peripheral angioplasty are developed. | |
| echopointmedical.com | 2018 | London, United Kingdom | $9.74M | 8 | Smart devices for monitoring coronary artery disease are developed. | |
| shapemem.com | 2009 | Santa Clara, United States | $77.27M | 37 | Embolization devices are developed using Shape Memory Polymer foams. | |
| limflow.com | 2012 | Paris, France | $97.45M | – | Developer a system for venous arterialization of the lower limbs | |
| terumo.com | 1921 | Somerset, United States | – | – | Portfolio of medical devices for interventional cardiology is provided. | |
| vasc.com | 1997 | Minneapolis, United States | $12M | 562 | Products for vascular diagnostics and interventional procedures are developed. | |
| ev3.net | 2000 | Plymouth, United States | $58.8M | 1,307 | Surgical products for treatment of Peripheral vascular & Neurovascular diseases | |
| relisysmedicaldevices.org | 1997 | Ranga Reddy, India | $23.63M | 250 | Medical devices for cardiovascular and structural heart treatments are supplied. |
Detailed competitors of Vascular Flow
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vascular Flow
Complete news archive for Vascular Flow
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Vascular Flow
10 companies that operate in the same segment as Vascular Flow (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vascular Flow
Vascular Flow was founded in 1998 and raised its 1st funding round 3 years after it was founded.
Vascular Flow is headquartered in Dundee, United Kingdom. It is registered at Dundee, Scotland, United Kingdom.
Vascular Flow is a funded company, having raised a total of $16.79M across 14 funding rounds to date. The company's 1st funding round was a Series A of $1.74M, raised on Jun 2001.
Vascular Flow has 10 employees.
Annual revenue of Vascular Flow is $206.45K as on Dec 31, 2018.
Vascular Flow was founded in 1998 in Dundee, United Kingdom, within the medical devices sector focused on vascular implants. Spiral Laminar Flow technology has been developed to restore natural blood flow patterns in prosthetic grafts, enhancing patency and addressing disease progression. Applications encompass the Spiral Flow peripheral bypass graft and the Spiral Flow arteriovenous access graft for hemodialysis support. Operations center on research and device production for clinical use.
Vascular Flow's top competitors include Contego Medical, Limflow and Shape Memory Medical.
Vascular Flow offers Spiral Laminar Flow Technology, Medical Device Development, and Contract Manufacturing.
Vascular Flow has 8 investors. Key investors include NHS Choices, Scottish Enterprise, 3i Group, European Union, and Braveheart Investment Group.
Vascular Flow operates through Vascular Flow Technologies Limited.
